Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 1/20 | 1.00 |
| ▸ | PPARG | P37231 | 3/20 | 0.69 |
| ▸ | PPARD | Q03181 | 3/20 | 0.69 |
| ▸ | PPARA | Q07869 | 1/20 | 0.69 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asarinin SCHEMBL29540276 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL29424131 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL30184024 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL3498030 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Sesamin SCHEMBL29988914 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL30384235 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Sesamin SCHEMBL23045677 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL94518 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL6704290 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 | |
| Asarinin SCHEMBL19313765 | 1.00 | MAPT (1.00) | MAPTCYP3A4TRPM8CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4229639-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS Global Biopharma, Inc. (CA) | 2023-08-23 | — | — | EP | claimed |
| WO-2022081889-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-21 | — | — | WO | claimed |
| US-20260014082-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | SAN EI GEN FFI INC (JP) | 2026-01-15 | — | — | US | disclosed |
| US-12453701-B2 | Solid composition containing amorphous, poorly water-soluble material, and method for producing same | SAN-EI GEN F.F.I., INC. (JP) | 2025-10-28 | — | — | US | disclosed |
| US-20230040337-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | SAN-EI GEN F.F.I., INC. (JP) | 2023-02-09 | — | — | US | disclosed |
| EP-3124032-B1 | ASARUM TOTAL POLYSACCHARIDES EXTRACT HAVING ANTITUSSIVE ACTIVITY AND EXTRACTION METHOD AND USE THEREOF | FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (CN) | 2022-11-02 | — | — | EP | disclosed |
| EP-4023246-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | San-Ei Gen F.F.I., INC. (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-114466641-A | Solid compositions containing non-crystalline poorly water soluble materials and methods of producing the same | 三荣源有限公司 | 2022-05-10 | — | — | CN | disclosed |
| US-20220130493-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-28 | — | — | US | disclosed |
| WO-2022081889-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014082-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | GC, CSNK1D, CCND3 | MAPT 1149/4885CYP3A4 3561/4885TRPM8 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.